Patterns of relapse and prognosis after bevacizumab failure in recurrent glioblastoma

Neurology. 2010 Apr 13;74(15):1239-41. doi: 10.1212/WNL.0b013e3181d8a293.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Adult
  • Angiogenesis Inhibitors / therapeutic use
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab
  • Glioblastoma / therapy*
  • Humans
  • Neoplasm Recurrence, Local
  • Prognosis

Substances

  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab